Radboud University Medical Center
Clinical trials sponsored by Radboud University Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could Plant-Based hospital drinks be as good as Milk-Based ones? a new study aims to find out Results expected Sep 2026 (estimated)
- Ventilator study aims to Fine-Tune breathing support for ICU patients Results expected Sep 2026 (estimated)
- App-Based lifestyle coaching tested as depression treatment in GP clinics Results expected Nov 2026 (estimated)
- Can a nanoparticle train the immune system to fight solid tumors? Results expected Dec 2026 (estimated)
- Could a common gout drug save hearts? colchicine trial targets valve disease Results expected Dec 2026 (estimated)
-
Can a website teach patients to tame gut pain and skip needless hospital tests?
Disease control OngoingUpper abdominal pain often comes from functional dyspepsia, irritable bowel syndrome, or uncomplicated gallstones. These conditions overlap and many patients do not know that tests and surgery may not help. Researchers are testing a personalized web-based education tool that expl…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for advanced thyroid cancer: personalized drug cocktails tested
Disease control OngoingThis early-phase trial tests whether giving advanced thyroid cancer patients a personalized mix of already-approved drugs, chosen based on their tumor's genetic profile, is feasible and safe. Ten patients with no other treatment options will receive individualized drug combinatio…
Phase 1 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a nanoparticle train the immune system to fight solid tumors?
Disease control OngoingThis first-in-human trial tests PRECIOUS-01, a nanoparticle designed to activate immune cells and target a tumor antigen called NY-ESO-1. The study enrolls adults with advanced or metastatic solid tumors that have not responded to standard treatments and that test positive for NY…
Phase 1 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a common gout drug save hearts? colchicine trial targets valve disease
Disease control OngoingThis phase 3 trial tests whether colchicine, an anti-inflammatory drug, can slow the progression of aortic valve stenosis—a narrowing of the heart's aortic valve that currently has no drug treatment. The study enrolls 150 people with moderate, symptom-free valve disease. Particip…
Phase 3 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can aggressive tumor removal boost survival in Multi-Organ colorectal cancer?
Disease control OngoingThis trial asks whether adding maximal tumor debulking—removing or destroying as many metastases as possible through surgery, heat ablation, chemo-embolization, or targeted radiation—to standard chemotherapy improves overall survival in people with colorectal cancer that has spre…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Which strategy wins for heart attack patients with multiple blocked arteries?
Disease control OngoingThis trial investigates the best way to treat people who have a heart attack and also have other narrowed arteries. It compares doing an immediate procedure to open those other arteries, guided by a pressure wire, versus waiting and using a heart scan to decide later. The goal is…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Could dropping aspirin after a heart attack save hearts?
Disease control OngoingThis trial asks whether giving only ticagrelor (a blood thinner) after a heart attack, instead of the usual ticagrelor plus aspirin, is just as safe and might reduce bleeding and heart muscle damage. About 200 people who had a type of heart attack called STEMI and underwent a ste…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
App-Based coaching aims to boost protein intake in seniors
Disease control By invitation onlyThis study tests whether a smartphone app that coaches older adults to eat more protein can help them maintain muscle mass and strength. Researchers will enroll 140 participants who are open to changing their diet and using an app. The app provides personalized nutritional coachi…
Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New study tests workplace coaching to keep Parkinson's patients on the job
Symptom relief OngoingThis study tests a personalized workplace intervention for 124 Dutch workers with Parkinson's disease, cerebellar ataxia, hereditary spastic paraparesis, or slowly progressive neuromuscular/mitochondrial disorders. A trained facilitator helps employees and their managers identify…
Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
Parkinson's patients try lifestyle overhaul: stress, exercise, sleep, and diet targeted
Symptom relief OngoingThis study tests whether a personalized lifestyle program focusing on stress, exercise, nutrition, sleep, and self-management can improve quality of life for people with Parkinson's disease. 256 participants will be randomly assigned to either work on their goals independently or…
Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Mindfulness therapy tested to calm Parkinson's stress
Symptom relief OngoingThis study tests whether mindfulness-based cognitive therapy (MBCT) can reduce psychological distress in people with Parkinson's disease. 174 participants with mild-to-moderate stress symptoms will either receive MBCT or continue usual care. The main goal is to see if MBCT lowers…
Sponsor: Radboud University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can brain scans predict who will benefit from tremor injections?
Knowledge-focused OngoingThis study looks at why botulinum toxin injections help only some people with arm tremor related to dystonia. Researchers will measure muscle activity, ultrasound, and brain imaging before treatment, then track tremor severity after three rounds of injections. The goal is to find…
Phase 4 • Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Marathoners' hearts under the microscope: is that plaque dangerous?
Knowledge-focused By invitation onlyThis study follows 250 male endurance athletes who were part of an earlier study to see how their heart arteries have changed over time. Researchers will use CT scans and AI to examine plaque buildup and determine if it is stable and harmless or likely to cause heart attacks. The…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Your genes may hold the key to predicting Post-Surgical pain
Knowledge-focused OngoingThis study aims to find out whether a person's genes and clinical profile can predict who will develop acute or chronic pain after major surgery. Researchers will follow 10,000 patients for one year after their operation, tracking pain levels and daily functioning. The goal is to…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Shock therapy vs. pills: which depression treatment wins on cost?
Knowledge-focused OngoingThis study looks at two treatments for severe depression: electroconvulsive therapy (ECT) and antidepressant medication. Researchers want to see which one works better and is more cost-effective in the long run. The study involves 220 adults in the Netherlands who have not gotten…
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC